BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22452617)

  • 1. Association of maturation period blood pressure with dialysis access patency.
    Wayne EJ; Brier ME; Dwyer AC
    Semin Dial; 2013; 26(1):90-6. PubMed ID: 22452617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.
    Flu H; Breslau PJ; Krol-van Straaten JM; Hamming JF; Lardenoye JW
    J Vasc Surg; 2008 Sep; 48(3):659-68. PubMed ID: 18572358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
    Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
    J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.
    Gibson KD; Gillen DL; Caps MT; Kohler TR; Sherrard DJ; Stehman-Breen CO
    J Vasc Surg; 2001 Oct; 34(4):694-700. PubMed ID: 11668326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.
    Jackson RS; Sidawy AN; Amdur RL; Khetarpal A; Macsata RA
    J Vasc Surg; 2011 Dec; 54(6):1706-12. PubMed ID: 21840155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A; Choudhury A; Ahmed Z; Choudhury D
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary loop grafts for hemodialysis access: midterm results from a single-center study.
    Jean-Baptiste E; Hassen-Khodja R; Haudebourg P; Declemy S; Batt M; Bouillanne PJ
    J Vasc Surg; 2008 Jan; 47(1):138-43. PubMed ID: 18178466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brachial artery-brachial vein fistula: expanding the possibilities for autogenous fistulae.
    Greenberg JI; May S; Suliman A; Angle N
    J Vasc Surg; 2008 Nov; 48(5):1245-50, 1250.e1-2. PubMed ID: 18971036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure.
    Steerman SN; Wagner J; Higgins JA; Kim C; Mirza A; Pavela J; Panneton JM; Glickman MH
    J Vasc Surg; 2013 Mar; 57(3):776-83; discussion 782-3. PubMed ID: 23313186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.
    Bakken AM; Protack CD; Saad WE; Lee DE; Waldman DL; Davies MG
    J Vasc Surg; 2007 Apr; 45(4):776-83. PubMed ID: 17398386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts.
    Woo K; Doros G; Ng T; Farber A
    J Vasc Surg; 2009 Dec; 50(6):1405-11.e1-2. PubMed ID: 19782518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
    Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
    J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular revascularization of chronically thrombosed arteriovenous fistulas and grafts for hemodialysis: a retrospective study in 15 patients with 18 access sites.
    Weng MJ; Chen MC; Chi WC; Liu YC; Liang HL; Pan HB
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):319-30. PubMed ID: 20585780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of hemodialysis-related central venous stenosis or occlusion: another option to maintain vascular access.
    Ayarragaray JE
    J Vasc Surg; 2003 May; 37(5):1043-6. PubMed ID: 12756352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era.
    Biuckians A; Scott EC; Meier GH; Panneton JM; Glickman MH
    J Vasc Surg; 2008 Feb; 47(2):415-21; discussion 420-1. PubMed ID: 18241764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.